Is MMR Global's Personal Health Records Patent Portfolio Worth A Closer Look? Print E-mail
By Adam Meadows, Contributor   
Wednesday, 23 January 2013 05:43
icon_stockresearchThe Michael Bass Group, an investment banking and strategic advisory services firm focused on healthcare information technology, healthcare IT services, healthcare mobility providers, medical technology and devices, today released a patent valuation report for MMR Global.

MMR Global (OTCQB : MMRF) with a current market cap of $10 million, provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups.  The independent research report shows that the potential value of the patents in the U.S. domestic market could be worth in a range as low as $600 Million to a high of $1.1 Billion, or 100 times the current market cap of the company.  In addition, MMR has many international patents as well that were not included in this evaluation.

According to a recent Press Release from the company, the Company now owns seven U.S. patents and has nearly 400 claims focused on the digital transmission of medical records, including Personal Health Records (PHRs). The Company also has additional U.S. patent applications pending, which include numerous continuation applications. Internationally, the Company has issued patents and pending applications in countries of commercial interest such as Australia, Singapore, New Zealand, Mexico, Canada, Hong Kong, Japan, South Korea, Israel, and European nations.

MMR has met with significant success in their early licensing efforts based on a five-plus year industry-wide awareness of the Company's intellectual property and its relevance to the market. In 2013, the Company will aggressively pursue infringement claims and plans on commencing litigation beginning this month against companies in healthcare, retail and other markets. The litigation just mentioned could potentially be key for a sharp appreciation in the stock price of MMR Global, as recent patent infringement plays have been red hot with traders and investors alike.

In addition, over the last month, MMR Global has entered into licensing agreements with EMR vendors, a laboratory reporting services vendor, a document management systems vendor providing services to more than 750 hospitals, and a Personal Health Record provider. They believe that this trend will continue which will provide a steady and ever increasing revenue stream to the company.

Based on government regulations and the breadth of its patent portfolio, MMR is well positioned to monetize its intellectual property given requirements under the law pertaining to HIPAA, the HITECH Act and Meaningful Use Stages 2 and 3. The Company believes hospitals, healthcare professionals and certain vendors responding to the current needs of the market will need licenses from the Company, or they could infringe upon MMR's portfolio of intellectual property.

Stay tuned for pending developments, as important catalysts may be set to occur in the days ahead.

A link to the Patent Valuation report is provided here:

As we cautioned in my previous article, MMR Global is a small company.  While they did do revenues of around $1.5M for the past fiscal year and are forecasting revenues of over $5M this year, they are not cash flow positive as of yet and do have debt.  Therefore any investment in these types of stocks does carry additional risk.


"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus